Literature DB >> 5314828

The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs.

C H Brown, M Turner-Warwick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5314828     DOI: 10.1093/oxfordjournals.qjmed.a067271

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


× No keyword cloud information.
  9 in total

1.  Desquamative fibrosing alveolitis unresponsive to steroid or cytotoxic therapy.

Authors:  S E Barnes; S Godfrey; G H Millward-Sadler; N R Roberton
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

2.  Fibrosing alveolitis: extrinsic allergic and cryptogenic.

Authors:  O P Sharma
Journal:  West J Med       Date:  1977-05

3.  AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

Authors:  Robert J Kaner; Kevin K Brown; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2017-05-01       Impact factor: 21.405

4.  The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease.

Authors:  G M Gyte; J M Willoughby
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.

Authors:  M A Johnson; S Kwan; N J Snell; A J Nunn; J H Darbyshire; M Turner-Warwick
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

6.  Fibrosing alveolitis in infancy and childhood.

Authors:  C J Hewitt; D Hull; J W Keeling
Journal:  Arch Dis Child       Date:  1977-01       Impact factor: 3.791

Review 7.  Fibrosing alveolitis.

Authors:  P Thomas
Journal:  Can Med Assoc J       Date:  1978-11-18       Impact factor: 8.262

8.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.

Authors:  J D Fulmer; W C Roberts; E R von Gal; R G Crystal
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

9.  Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.

Authors:  J A Moolman; P G Bardin; D J Rossouw; J R Joubert
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.